Hazra, M. 2019. A rational pharmacotherapeutic study of comparative safety among topical anti-acne 1% nadifloxacin monotherapy, 0.1% adapalene monotherapy, 0.025% tretinoin monotherapy, 1% nadifloxacin and 0.1% adapalene combination therapy and 1% nadifloxacin and 0.025% tretinoin combination therapy, in mild to moderate acne vulgaris, in tertiary care hospitals. International Journal of Basic & Clinical Pharmacology. 8, 9 (Aug. 2019), 1959–1965. DOI:https://doi.org/10.18203/2319-2003.ijbcp20193662.